Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
Ortin Global Ltd.
₹14.80
₹14.80
₹15.47
₹9.93
₹19.90
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0.01 | 0.01 | 0.04 | 0.09 | 0.03 |
| Operating Expense | 0.06 | 0.52 | 0.24 | 0.25 | 0.17 |
| Operating Profit | -0.05 | -0.50 | -0.20 | -0.16 | -0.13 |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | -0.01 |
| Tax | 0 | 0 | 0.01 | 0 | 0.01 |
| Net Profit | -0.05 | -0.50 | -0.18 | -0.16 | -0.11 |
₹14.80
↗ Bullish Moving Average
14
↘ Bearish Moving Average
2
| Held By | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoter | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 |
| FII | 6.2 | 6.2 | 6.5 | 6.5 | 1.7 | 1.7 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 92.5 | 92.5 | 92.2 | 92.2 | 97.1 | 97.1 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 1.09 K | 1.09 K | 100.00% |
| Week | 9.3 K | 9.3 K | 100.00% |
| 1 Month | 7.59 K | 7.59 K | 100.00% |
| 6 Month | 18.49 K | 20.08 K | 92.08% |
Companies with 10% increase in share price over three months, with rising net profit growth
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Low Debt
Companies with reducing Debt
Companies with Zero Promoter Pledge
Stock with Low PE (PE < = 10)
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 24 Sep, 2013 | 0.25 | FINAL | Equity Share | |
| 24 Sep, 2012 | 0.5 | FINAL | Equity Share | |
| 13 Oct, 2011 | 0.5 | FINAL | 15 Oct, 2011 | Equity Share |
| 23 Sep, 2010 | 0.8 | FINAL | Equity Share | |
| 23 Sep, 2009 | 0.8 | FINAL | Equity Share | |
| 24 Sep, 2008 | 0.8 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹425 | ₹7.01 | ₹105.93 | ₹122.50 | ₹530.80 | ₹803.40 |
| % Change | 0.77% | 4.94% | -3.20% | 2.60% | -0.52% | 2.57% |
| Revenue TTM (₹ Cr) | - | ₹83.60 | ₹282.74 | - | ₹488.20 | ₹588.52 |
| Net Profit TTM (₹ Cr) | - | ₹-34.95 | ₹15.30 | - | ₹56.90 | ₹101.60 |
| PE TTM | - | -1.70 | 26.90 | - | 27.00 | 36.50 |
| 1 Year Return | 7.83 | 601 | -15.85 | 33.64 | -15.37 | 54 |
| ROCE | 28.91 | -5.63 | - | - | 23.87 | 9.34 |
Innova Captab Ltd.
₹ 679.95
-0.47%
Valiant Laboratories Ltd.
₹ 57.50
-4.01%
Sigachi Industries Ltd.
₹ 20.70
-1.29%
Windlas Biotech Ltd.
₹ 798.00
+1.30%
Vineet Laboratories Ltd.
₹ 33.15
+2.66%
Solara Active Pharma Sciences Ltd.
₹ 480.10
-0.64%
Zim Laboratories Ltd.
₹ 70.11
-1.23%
Medico Remedies Ltd.
₹ 38.48
-1.64%
Dishman Carbogen Amcis Ltd.
₹ 158.00
-2.48%
Lasa Supergenerics Ltd.
₹ 7.51
+4.16%
Advanced Enzyme Technologies Ltd.
₹ 290.20
-0.90%
Bajaj Healthcare Ltd.
₹ 324.90
-0.23%
Brooks Laboratories Ltd.
₹ 71.93
+0.28%
RPG Life Sciences Ltd.
₹ 1890.00
+0.93%
Bafna Pharmaceuticals Ltd.
₹ 136.13
+10.00%
Alpa Laboratories Ltd.
₹ 70.00
-0.34%
Sun Pharma Advanced Research Company Ltd.
₹ 145.72
+7.02%
SMS Pharmaceuticals Ltd.
₹ 415.00
+3.96%
Nectar Lifesciences Ltd.
₹ 10.74
-0.46%
Mangalam Drugs and Organics Ltd.
₹ 32.49
+2.91%
Indoco Remedies Ltd.
₹ 202.75
+2.29%
Ind-Swift Laboratories Ltd.
₹ 143.48
-4.52%
Lincoln Pharmaceuticals Ltd.
₹ 546.00
-1.14%
By signing up I certify terms, conditions & privacy policy